Growth Metrics

Dexcom (DXCM) Net Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -51.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 129.29%
Dec 31, 2025 -145.09%
Sep 30, 2025 190.79%
Jun 30, 2025 115.96%
Mar 31, 2025 42.34%
Dec 31, 2024 78.48%
Sep 30, 2024 -46.40%
Jun 30, 2024 -40.57%
Mar 31, 2024 76.02%
Dec 31, 2023 -37.20%
Sep 30, 2023 -80.04%
Jun 30, 2023 131.44%
Mar 31, 2023 -28.96%
Dec 31, 2022 -48.42%
Sep 30, 2022 54.20%
Jun 30, 2022 26.85%
Mar 31, 2022 -62.19%
Dec 31, 2021 -35.91%
Sep 30, 2021 62.59%
Jun 30, 2021 77.13%
Mar 31, 2021 -61.36%
Dec 31, 2020 52.69%
Sep 30, 2020 232.06%
Jun 30, 2020 -30.58%
Mar 31, 2020 32.91%
Dec 31, 2019 152.43%
Sep 30, 2019 -218.54%
Jun 30, 2019 -292.95%
Mar 31, 2019 171.66%
Dec 31, 2018 885.71%
Sep 30, 2018 55.99%
Jun 30, 2018 -121.29%
Mar 31, 2018 -4.18%
Dec 31, 2017 67.20%
Sep 30, 2017 -34.22%
Jun 30, 2017 300.11%
Mar 31, 2017 187.16%
Dec 31, 2016 -33.08%
Sep 30, 2016 25.59%
Jun 30, 2016 1.76%
Mar 31, 2016 -40.26%
Dec 31, 2015 -37.65%
Sep 30, 2015 155.44%
Jun 30, 2015 156.50%
Mar 31, 2015 -106.22%
Dec 31, 2014 37.07%
Sep 30, 2014 41.55%
Jun 30, 2014 -49.83%
Mar 31, 2014 63.63%
Dec 31, 2013 152.72%
Sep 30, 2013 129.19%